Medicine and Dentistry
Positron Emission Tomography-Computed Tomography
100%
Positron Emission Tomography
66%
Fluorodeoxyglucose F 18
39%
Neoplasm
37%
Positron Emission Tomography
35%
Fluorine-18
32%
Nuclear Medicine
27%
Posttransplant Lymphoproliferative Disease
22%
Radioactive Tracer
21%
Prostate Cancer
21%
Biological Marker
20%
Radiology
20%
Amyloidosis
19%
Image Quality
19%
Neuroendocrine Tumor
16%
DOPA
16%
Sympathetic Innervation
16%
Diagnosis
15%
Iodine 123
14%
Head and Neck Cancer
14%
Radiation Therapy
14%
Single-Photon Emission Computed Tomography
13%
Prostate Specific Membrane Antigen
13%
Esophageal Cancer
12%
Molecular Imaging
11%
Disease
11%
Xerostomia
11%
Radiomics
11%
Lutetium 177
10%
Recurrent Disease
10%
(3 Iodobenzyl)guanidine
10%
Chemoradiotherapy
10%
Computer Assisted Tomography
9%
Carbon 11
9%
Dosimetry
9%
Heart Amyloidosis
9%
Standardized Uptake Value
9%
Single Photon Emission Computed Tomography-Computed Tomography
9%
Metastatic Carcinoma
9%
Nuclear Medicine Physician
9%
Tetraxetan
8%
ATTR Amyloidosis
8%
Scintigraphy
8%
Necrosis
7%
Denervation
7%
Echocardiography
7%
Radioisotope
7%
Polyethylene Terephthalate
6%
Gallium 68
6%
Bone Scintigraphy
6%
Keyphrases
Positron Emission Tomography-computed Tomography (PET-CT)
23%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
22%
Cardiac Sympathetic Denervation
13%
Long Axial Field of View PET
12%
Single-photon Emission Computed Tomography (SPECT)
12%
Whole-body
11%
Patlak
11%
Nuclear Medicine
10%
Post-transplant Lymphoproliferative Disorder
9%
18F-FDG PET-CT
9%
Digital Biomarkers
9%
Input Function
9%
Population-averaged
8%
Nuclear Imaging
8%
Standardized Uptake Value
7%
FDG-PET Scan
7%
Prostate-specific Membrane Antigen Positron Emission Tomography
7%
Biograph Vision Quadra
7%
F-18
6%
Netherlands
6%
18F-fluorodeoxyglucose (18F-FDG)
6%
Molecular Imaging
6%
Radiology Residency
6%
Nuclear Radiology
6%
Residency Program
6%
PET Image
6%
Prostate-specific Antigen
6%
Radiation-induced Xerostomia
6%
Xerostomia
5%
123I-MIBG
5%
Tumor
5%
18F-fluorodeoxyglucose PET
5%